Article
type: Class

Document
type: Class

Anualidad
type: Class

Information Content Entity
type: Class

Continuant
type: Class

Entity
type: Class

2021
type: Class

Congress communication
type: Class

Generically Dependent Continuant
type: Class

Conference Paper
type: Class

individual
type: Document
rights: termsOfUse
date: 2026-08-30T01:47:49
publisher: Evaluation of six population pharmacokinetic models of adalimumab in patients with inflammatory bowel disease in clinical practice
label: RDF description of Evaluation of six population pharmacokinetic models of adalimumab in patients with inflammatory bowel disease in clinical practice - http://research.umh.es/vivo/pub/comunicacion/224827

Evaluation of six population pharmacokinetic models of adalimumab in patients with inflammatory bowel disease in clinical practice
type: Congress communication
related by: Autor:131518-Comunicación:224827
date time value: 224827 pubdate
most specific type: Congress communication
type: Information Content Entity
included: Ingeniería 2021
most specific type: 2021
type: Anualidad
related by: Autor:107162-Comunicación:224827
type: Continuant
type: 2021
type: Document
type: Conference Paper
RO_0002353: 19TH CONGRESS OF THERAPEUTIC DRUG MONITORING & CLINICAL TOXICOLOGY / IATDMCT
related by: AutorExt:357672_2021-Comunicación:224827
related by: Autor:243759-Comunicación:224827
ARG_2000028: 224827 vcard
type: Article
most specific type: Conference Paper
type: Entity
related by: Autor:121815-Comunicación:224827
included: Modelización y Simulación farmacocinética y farmacodinámica. Desde el desarrollo de fármacos hasta la individualización farmacoterapéutica. 2021
type: Thing
type: Generically Dependent Continuant

Autor:131518-Comunicación:224827
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Evaluation of six population pharmacokinetic models of adalimumab in patients with inflammatory bowel disease in clinical practice

Ingeniería 2021
type: Anualidad
type: 2021
type: DepartmentReport
type: Thing
type: ResearchReport
includes: Evaluation of six population pharmacokinetic models of adalimumab in patients with inflammatory bowel disease in clinical practice

Autor:107162-Comunicación:224827
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Evaluation of six population pharmacokinetic models of adalimumab in patients with inflammatory bowel disease in clinical practice

19TH CONGRESS OF THERAPEUTIC DRUG MONITORING & CLINICAL TOXICOLOGY / IATDMCT
type: BFO_0000003
RO_0002234: Evaluation of six population pharmacokinetic models of adalimumab in patients with inflammatory bowel disease in clinical practice
type: 2021
type: Conference
type: BFO_0000015
type: Entity
type: Event
type: Thing
type: Anualidad

AutorExt:357672_2021-Comunicación:224827
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Evaluation of six population pharmacokinetic models of adalimumab in patients with inflammatory bowel disease in clinical practice

Autor:243759-Comunicación:224827
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Evaluation of six population pharmacokinetic models of adalimumab in patients with inflammatory bowel disease in clinical practice

Autor:121815-Comunicación:224827
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Evaluation of six population pharmacokinetic models of adalimumab in patients with inflammatory bowel disease in clinical practice

Modelización y Simulación farmacocinética y farmacodinámica. Desde el desarrollo de fármacos hasta la individualización farmacoterapéutica. 2021
type: ResearchOrganizationReport
type: Anualidad
type: 2021
type: Thing
type: ResearchReport
includes: Evaluation of six population pharmacokinetic models of adalimumab in patients with inflammatory bowel disease in clinical practice